Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio With Transcatheter Mitral Valve Repair Outcomes: A Secondary Analysis of the COAPT Trial.
Lindenfeld J, Abraham WT, Grayburn PA, Kar S, Asch FM, Lim DS, Nie H, Singhal P, Sundareswaran KS, Weissman NJ, Mack MJ, Stone GW; Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (COAPT) Investigators. Lindenfeld J, et al. Among authors: sundareswaran ks. JAMA Cardiol. 2021 Apr 1;6(4):427-436. doi: 10.1001/jamacardio.2020.7200. JAMA Cardiol. 2021. PMID: 33533873 Free PMC article. Clinical Trial.
The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device.
Rich JD, Gosev I, Patel CB, Joseph S, Katz JN, Eckman PM, Lee S, Sundareswaran K, Kilic A, Bethea B, Soleimani B, Lima B, Uriel N, Kiernan M; Evolving Mechanical Support Research Group (EMERG) Investigators. Rich JD, et al. J Heart Lung Transplant. 2017 Jan;36(1):50-58. doi: 10.1016/j.healun.2016.08.010. Epub 2016 Aug 20. J Heart Lung Transplant. 2017. PMID: 27746085 Clinical Trial.
Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients.
Teuteberg JJ, Ewald GA, Adamson RM, Lietz K, Miller LW, Tatooles AJ, Kormos RL, Sundareswaran KS, Farrar DJ, Rogers JG. Teuteberg JJ, et al. Among authors: sundareswaran ks. J Am Coll Cardiol. 2012 Jul 3;60(1):44-51. doi: 10.1016/j.jacc.2012.02.032. Epub 2012 Apr 25. J Am Coll Cardiol. 2012. PMID: 22541834 Free article.
Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
Boyle AJ, Jorde UP, Sun B, Park SJ, Milano CA, Frazier OH, Sundareswaran KS, Farrar DJ, Russell SD; HeartMate II Clinical Investigators. Boyle AJ, et al. Among authors: sundareswaran ks. J Am Coll Cardiol. 2014 Mar 11;63(9):880-8. doi: 10.1016/j.jacc.2013.08.1656. Epub 2013 Dec 11. J Am Coll Cardiol. 2014. PMID: 24316083 Free article.
High Transpulmonary Artery Gradient Obtained at the Time of Left Ventricular Assist Device Implantation Negatively Affects Survival After Cardiac Transplantation.
Uriel N, Imamura T, Sayer G, Agarwal R, Sims DB, Takayama H, John R, Pagani FD, Naka Y, Sundareswaran KS, Farrar DJ, Jorde UP; Heartmate II Clinical Investigators. Uriel N, et al. Among authors: sundareswaran ks. J Card Fail. 2019 Oct;25(10):777-784. doi: 10.1016/j.cardfail.2019.03.010. Epub 2019 Mar 20. J Card Fail. 2019. PMID: 30904557 Clinical Trial.
Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.
Park SJ, Milano CA, Tatooles AJ, Rogers JG, Adamson RM, Steidley DE, Ewald GA, Sundareswaran KS, Farrar DJ, Slaughter MS; HeartMate II Clinical Investigators. Park SJ, et al. Among authors: sundareswaran ks. Circ Heart Fail. 2012 Mar 1;5(2):241-8. doi: 10.1161/CIRCHEARTFAILURE.111.963991. Epub 2012 Jan 26. Circ Heart Fail. 2012. PMID: 22282104 Clinical Trial.
57 results